News Daily News New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration L.A. McKeown December 18, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Conference News EAS 2018 ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran Yael L. Maxwell May 14, 2018
News Conference News ACC 2018 High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab Michael O'Riordan March 20, 2018
News Conference News ACC 2018 Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial Caitlin E. Cox March 14, 2018
News Daily News High Rate of Clinical Events at 6 Months for Ischemic CVD Patients Michael O'Riordan January 19, 2018
News Conference News AHA 2017 Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events Michael O'Riordan November 17, 2017
News Daily News More CVD and Stroke Drive Shorter Life Spans in African-Americans: AHA Michael O'Riordan October 24, 2017
News Daily News Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests Michael O'Riordan October 20, 2017
News Daily News NOAC Bleeding Risk Rises With Several Drug Combinations Michael O'Riordan October 06, 2017
Presentation VIVA 2017 Is Aspirin Really a Class I Medication in Peripheral Artery Disease? Presenter: Ehrin J. Armstrong September 19, 2017
News Conference News ESC 2017 COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease Todd Neale August 27, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
News Daily News How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues Leah Lawrence August 01, 2017
News Daily News Long-term Ticagrelor Post-MI of ‘Intermediate Value’: Cost-Effectiveness Study Leah Lawrence July 24, 2017
News Daily News 3-D Ultrasound Quantifies Plaque Burden in Healthy Middle-Aged Cohort Michael O'Riordan July 11, 2017
News Daily News ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events Michael O'Riordan April 04, 2017
News Daily News Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS Todd Neale February 08, 2017